Hikma Testosterone Enanthate Injection is an injectable testosterone product used to treat men with low testosterone (hypogonadism). It may also be used off-label in gender-affirming hormone therapy for transgender men and some nonbinary individuals, as well as in select cases for women. It is given by injection and releases testosterone gradually over time.
In Canada, this product is available as a 200 mg/mL solution in a multi-dose vial. Compared to the only other injectable option in Canada (testosterone cypionate), its higher concentration means each dose can be given in a smaller volume. This can make injections more comfortable, especially for people using injectable testosterone long term who may have irritation or scar tissue at injection sites.
Hikma testosterone enanthate is formulated in sesame oil. This matters for people with allergies or sensitivities, as testosterone cypionate is typically made with cottonseed oil. Some patients find they tolerate one better than the other.
Compared to gels or nasal products, injectable testosterone does not need to be used daily, which many people find more convenient. However, depending on the dosing schedule, testosterone levels can rise and fall more noticeably between doses.
Like all testosterone products, this medication is used on an ongoing basis. If shortages occur, switching to another product may be necessary. Because different formulations (such as gels or other injectables) behave differently in the body, dose adjustments and monitoring are usually required when changing treatments.
Because there are only two injectable options in Canada, shortages of either product can quickly affect availability nationwide.
Public Coverage
Hikma Testosterone Enanthate Injection is listed on many provincial and territorial public drug plans in Canada, but coverage depends on clinical criteria, prior authorization, and individual eligibility.
We don’t collect your email. This uses a third-party service to notify you when this page changes.